The MM+M Podcast is Medical Marketing + Media’s show about healthcare marketing writ large. Each week, hosts Marc Iskowitz and Larry Dobrow — senior editors at the publication — interview the executives commercializing brands, the agencies supporting launches, and other fascinating guests from in and around the industries of pharma, biotech, med-tech ad-tech and health media.
Hensley Evans of ZS Associates drops in to discuss her new book on patient-centricity, and why pharma is taking so long to put patients at the forefront.
MM+M’s Stephen Madden sits down with Janis Cohen and Dan Weber of Havas Health & You to discuss their pro-bono work seeking to destigmatize mental illness and more.
Subin Baral, global life sciences deals leader at EY, shares his research-based predictions for where biopharma dealmaking could be headed in the second half.
Sharon Jhawar, chief pharmacy officer, and Timshel Tarbet, VP of business excellence and diversity strategy, discuss the plan’s effort to reduce disparities in medication adherence.
Adam Ricciardone, global head of self care R&D at Johnson & Johnson Consumer Health, discusses how Tylenol embraced a “beyond-the-pill” strategy.
MM+M’s Stephen Madden speaks with Iris Yim, VP, Asian American Advertising Federation and Founder/ President, Sparkle Insights, Inc. about confronting anti-Asian bias and more.
MM+M’s Stephen Madden speaks with Horace Clark, vp of account management, BlackDoctor.org, about understanding and working to overcome the Black community’s distrust of the healthcare system.
MM+M’s Stephen Madden speaks with John Liliquist, SVP Health, iHeartMedia, about the state of the union for terrestrial radio, how health brands are evolving their targeting and measurement approaches for broadcast audio, and more.
Wayne Pines joins the show to discuss a recent report that the agency is looking to tap a skilled public communicator to improve its messaging.
Rob Jekielek, managing director of the Harris Poll, comments on reputational data showing that pharma’s positive image is still high above pre-pandemic levels.
From the panel discussions to the keynote fireside, here are audio snippets and commentary from MM+M’s Women of Distinction 2022 educational summit.
Patrick Wisnom, the new CEO of Wunderman Thompson Health, explains what it’s like to be back in Cannes after the festival’s three-year hiatus, opines on the drop in awards entries, and more.
Klick Health’s Rich Levy, chief creative officer, and Bernardo Romero, maker, share their impressions of the winning work and more.
In this mini-episode, Steve Madden talks with Paul Matsen, chief marketing and communications officer for the Cleveland Clinic.
Franklin Williams, a Pharma Lions juror who’s also EVP, director of experience design at Area 23, talks about his experience as a jurist and Area 23’s two Lion-winning campaigns.
Preferential treatment for orphan drugs is very much in play overseas. Jack Mycka, VP in the PRMA division of Indegene, explains what potential European reforms could mean for pharma marketers.
Larry Dobrow and Marc Iskowitz discuss what to expect — and how to get the most out of — MM+M’s Agency 100 content package, which goes live Tuesday, June 7.
Lisa Suennen, a healthcare VC, opines on whether the voiding of California’s Women on Boards law by an L.A. judge may hamper ongoing board diversity efforts.
With SCOTUS poised to strike down Roe v. Wade, telemedicine abortion providers are ramping up their communication about safe access.
From the opening keynote to the closing one, here are audio snippets from the full MM+M Transform program.